首页 | 官方网站   微博 | 高级检索  
     


Monotherapy with a novel intervenolin derivative,AS‐1934, is an effective treatment for Helicobacter pylori infection
Authors:Tomokazu Ohishi  Tohru Masuda  Hikaru Abe  Chigusa Hayashi  Hayamitsu Adachi  Shun‐ichi Ohba  Masayuki Igarashi  Takumi Watanabe  Hitomi Mimuro  Eri Amalia  Daniel Ken Inaoka  Kota Mochizuki  Kiyoshi Kita  Masakatsu Shibasaki  Manabu Kawada
Affiliation:1. Institute of Microbial Chemistry (BIKAKEN), Numazu, Microbial Chemistry Research Foundation, Numazu‐shi, Shizuoka, Japan;2. Institute of Microbial Chemistry (BIKAKEN), Laboratory of Synthetic Organic Chemistry, Microbial Chemistry Research Foundation, Shinagawa‐ku, Tokyo, Japan;3. Institute of Microbial Chemistry (BIKAKEN), Laboratory of Microbiology, Microbial Chemistry Research Foundation, Shinagawa‐ku, Tokyo, Japan;4. Division of Bacteriology, Department of Infectious Diseases Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Minato‐ku, Tokyo, Japan;5. Division of Infectious Disease, Department of Infection Microbiology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan;6. Department of Biomedical Chemistry, The University of Tokyo, Bunkyo‐ku, Tokyo, Japan;7. School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki‐shi, Nagasaki, Japan;8. Department of Immunogenetics, Institute of Tropical Medicine, Nagasaki University, Nagasaki‐shi, Nagasaki, Japan;9. Institute of Microbial Chemistry (BIKAKEN), Laboratory of Oncology, Microbial Chemistry Research Foundation, Shinagawa‐ku, Tokyo, Japan
Abstract:
Keywords:DHODH  H     pylori infection  urease
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号